Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $45M | $38.19M | +17.83% |
Operating Income | $-397.82M | $-375.4M | -5.97% |
Net Income | $-390.12M | $-349.03M | -11.77% |
EPS (Basic) | $-3.99 | $-3.96 | -0.76% |
EPS (Diluted) | $-3.99 | $-3.96 | -0.76% |
R&D Expense | $349.43M | $326.09M | +7.16% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $1.17B | $1.24B | -5.63% |
Current Assets | $710.9M | $893.49M | -20.44% |
Total Liabilities | $210.74M | $205.94M | +2.33% |
Current Liabilities | $105.68M | $91.95M | +14.93% |
Stockholders' Equity | $962.62M | $1.04B | -7.21% |
Cash & Equivalents | $120.5M | $168.03M | -28.29% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-263.69M | $-301.03M | +12.41% |
Investing Cash Flow | $-26M | $-77.29M | +66.36% |
Financing Cash Flow | $183.43M | $23.84M | +669.45% |
D&A | $7.72M | $6.51M | +18.57% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -884.0% | -982.9% | +98.95% |
Net Margin | -866.9% | — | — |
ROE | -40.5% | — | — |
ROA | -33.2% | — | — |
Current Ratio | $6.727 | — | — |
Debt to Equity | $0.219 | — | — |
Other companies in Biotechnology